If you are a clinician working in a paralysis tick area of Australia then you’ll be well aware of the 2022 shortage of tick antiserum, and you very likely have some questions, like how do we ensure that we still do the best for our patients, where do our previous dose rates for TAS even come from, and why is it suddenly ok for us to use less? You might even be wondering how the vet boards will view deviations from the label dose if that’s what we’re required to do in response to the shortage.
We’ve gathered some of the smartest people on the topic to get your questions answered. The smart people in question are Prof Rick Atwell, Dr Terry King, Dr Heather Russel and Dr Rob Webster, who are all members of the Tick Paralysis Advisory Panel, a group of veterinary and scientific experts who convene to review the latest scientific information regarding the prevention and management of tick paralysis to provide guidance and recommendations to vets and pet owners. This discussion covers what we know (and what we think we know!) about paralysis ticks, their toxins and how it relates to antiserum dose, as well as new insights around managing tick cases beyond just TAS.
If you want to lift your clinical game, go to vvn.supercast.com for a free 2-week trial of our short and sharp high-value clinical podcasts.
And if you like what you hear then please share the love by clicking on the share button wherever you’re listening and sending a link to someone who you know will enjoy listening.
Support the pets of Ukraine here.
Get new episode alerts and vet vault updates direct to your inbox. Join our newsletter today.